Healthcare is changing fast. With rising costs, aging populations and stretched provider systems, innovation isn’t optional — it’s urgent. Today’s top-funded startups aren’t just tinkering around the edges; they’re rewriting how medicine gets delivered, how data flows, how outcomes are measured.
In the past six months, U.S. digital-health startups raised record capital, and Europe & the Middle East are stepping into the ring with serious ambition. What that tells us: the winners will be the ones who can scale across geography, regulation, and business models.
Here are ten healthcare startups — across diagnostics, prevention, provider workflow, consumer health — that just raised meaningful rounds, and whose next moves could reshape their sectors.
1. Abridge (USA) —
“Ambient AI for the doctor-room”
What they do: Abridge uses ambient-listening AI to turn doctor-patient conversations into structured clinical notes, codes and workflow items.
Founder(s): Dr Shiv Rao (CEO & Co-Founder), Florian Metze (CSO), Sandeep Konam (CTO)
Funding & backers: Raised US $300 million in Series E led by Andreessen Horowitz (a16z) and joined by Khosla Ventures, valued at ~$5.3 billion.
Best for you if you: You run a health-system or provider network hung up on documentation burdens, want to free clinicians to care instead of type, and need workflow automation integrated with large EHR systems.
Next moves: Expand from outpatient into inpatient documentation and revenue cycle applications; deepen integrations with major EHRs; move internationally beyond the U.S.
2. Neko Health (Europe / USA) —
“Full-body scan meets preventive care”
What they do: Provide a non-invasive full-body preventive health scan (imaging, sensors, bloodwork) aimed at early detection and wellness.
Founder(s): Hjalmar Nilsonne (CEO & Co-Founder), Daniel Ek (Co-Founder)
Funding & backers: Raised US $260 million in Series B (Jan 2025), led by Lightspeed Venture Partners, with participation by General Catalyst, O.G. Venture Partners, Lakestar and Atomico. Valuation ~US$1.8 billion.
Best for you if you: You are in the wellness/preventive health space, an insurer interested in early detection, or a diagnostic-partner seeking expansion into high-volume preventative models.
Next moves: U.S. market launch, expand scan centres beyond London/Stockholm, scale R&D into new diagnostics and imaging modalities.
3. Nourish (USA) —
“Nutrition‐care becomes clinical care”
What they do: Virtual nutrition-care platform connecting patients with registered dietitians, integrating AI and targeted services (including GLP-1 drug users) to support weight, chronic-disease patients.
Founder(s): Sam Perkins, Stephanie Liu, Aidan Dewar
Funding & backers: US $70 million Series B (Apr 2025) led by J.P. Morgan Private Capital Growth Equity Partners; total funding ~$115 million; reached “unicorn” status.
Best for you if you: Work with employers, insurers or platforms in wellness and chronic-care looking to embed nutrition as a clinical service and partner with dietitian network + tech.
Next moves: Expand AI-driven nutrition modules, deepen strategic partnerships with payers/providers, expand nationally/internationally.
4. Function Health (USA) —
“Personalised diagnostics for every body”
What they do: A membership platform offering consumers access to comprehensive lab tests (100+ biomarkers), imaging, diagnostics, data insights, aimed at preventive and longevity health.
Founder(s): Mark Hyman, Jonathan Swerdlin, Daniel Swerdlin, Mike Nemke, Pranitha Patil, Seth Weisfeld
Funding & backers: Series A ~$53 million led by a16z (June 2024). Other reports suggest a Series B (May 2025) ~US$300 million (unofficial).
Best for you if you: Operate in the wellness/longevity consumer health space or diagnostics channel and want to partner with a company scaling diagnostics membership models.
Next moves: Expand scan/imaging lineup, integrate richer data analytics, expand membership base globally.
5. Freenome (USA) —
“Early-cancer detection via liquid-biopsy”
What they do: Use genomics + AI to detect early stage cancers from blood tests (liquid biopsy) aimed at high-impact diagnostics. (Note: Less recent public raise in our list but remains high-profile)
Founder(s): (Not listed here)
Funding & backers: Large VC support; major backers in AI/health space via a16z/Bio-Health fund.
Best for you if you: Are a diagnostics partner, biotech/health system looking at early-detection or precision-health and want to see how blood-based screens gain traction.
Next moves: Regulatory milestones, commercialization partnerships with hospitals/payers, scaling platform globally.
6. Devoted Health (USA) —
“Medicare-era plan meets tech-enabled care”
What they do: A health-plan/provider hybrid model for older populations combining care-management tech, data, member experience—part of the value-based care wave.
Founder(s): (Not specifically listed here)
Funding & backers: Among the highest-funded in health-tech; exact recent round not in detail here.
Best for you if you: Operate in payer/insurer/provider space and want to partner with startups disrupting Medicare or value-based models.
Next moves: Expand into new states/markets, deepen tech-platform, scale care-model outcomes.
7. Lyra Health (USA) —
“Mental-health meets enterprise scale”
What they do: Behavioural-health platform offering digital/therapy/coaching to employers and health systems at scale.
Founder(s): (Not detailed here)
Funding & backers: Raised very large funding (~US$900 million in past).
Best for you if you: Are in employer-health, digital health integration or wellness and want to embed behavioural health solutions.
Next moves: Global roll-out, deeper data-integration, assimilation into primary-care workflows.
8. Omada Health (USA) —
“Digital chronic-care that lives beyond apps”
What they do: Digital chronic-disease management platform (diabetes, hypertension, obesity) combining human coaching, platform tech, scaling via payers/providers.
Founder(s): (Not detailed here)
Funding & backers: Large funding and considered IPO candidate.
Best for you if you: Work in chronic-care, value-based care models, or want to partner with digital platforms scaling beyond consumer apps into enterprise.
Next moves: Expand into new chronic conditions, scale payer/provider partnerships, prepare for IPO or major merger.
9. Doctolib (Europe) —
“Europe’s care-platform play: bookings, telehealth, provider-ecosystem”
What they do: Telehealth + appointment-booking + provider tools, widely used across Europe in multiple countries.
Founder(s): (Not detailed here)
Funding & backers: Raised significant funding (>US$800 million) and strong European presence.
Best for you if you: Target Europe (or cross-border Europe/USA) and want partnership with a platform scaling digital care & provider workflow.
Next moves: Expand into more European countries, deepen full-stack care tools (beyond booking) into hospital/insurer networks.
10. K Health (USA) —
“Virtual primary care + AI-triage for millions”
What they do: AI-powered virtual primary care (symptom check, triage, tele-visits) integrated with insurers/health systems.
Founder(s): Allon Bloch, Ran Shaul, Israel Roth, Adam Singolda
Funding & backers: Raised ~US$380 million; valued ~US$900 million as of mid-2024.
Best for you if you: Love virtual care, primary-care disruption, digital front-end for health services and want to connect with a company scaling that model.
Next moves: Expand membership/virtual-care model, international launch, deepen AI triage + chronic-care management.
How to Spot the Right Healthcare-Startup Partner
When you scan these ten stories, a few patterns become clear — things you should ask for if you are evaluating a partner or monitoring a startup:
- Domain-depth: Do they understand the clinical context (regulations, workflows, provider pain-points) — not just “tech that looks cool”.
- Real traction: Scaling pilots, deployments, partnerships with health systems or insurers — not just an idea.
- Regulatory & data readiness: Healthcare isn’t in the wild-west — data privacy, security, billing, reimbursement matter.
- Interoperability/Real-world use: Can they integrate with existing systems (EHRs, payers, labs)?
- Scalable business model: Is this a niche pilot, or a model built for tens of thousands/millions of users?
- Next-move clarity: They’ve raised large funds — what will they do next (geographic expansion, product lines, partnerships)?
- Partner-friendly design: If you’re looking to work with them (either as client, reseller, investor) how open are they to collaboration, co-innovation?
Final Thoughts
Here’s the story: A handful of companies step up — they raise significant funding, prove an idea, then go for scale. For you (and your team at McArrows), the opportunity lies in these scale-junctions. When a healthcare startup has “got the tech, validated the product, raised a round, now must expand” — that’s when they need stronger outreach, messaging, go-to-market execution, product/design integration.
Imagine: A U.S. diagnostics startup has proven its scan tech, now prepares to launch in Europe; or a telehealth platform is moving from consumer to employer space; or a nutrition-tech company is integrating deeply into insurer care-management workflows. These are the moments where your product & marketing muscle becomes meaningful.
If you’re reading this thinking: “Yes — I’m the healthcare startup raising (or about to raise) and scaling globally — we need messaging, sales funnel, partner outreach, product positioning” — then this is your moment to align funding energy with execution velocity.
